Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2012 - 2013)
Jazz Pharmaceuticals' (JAZZ) quarterly Gains from Investment Securities came in at -$12.9 million in Q3 2013, down 1333.33% year-on-year from $1.0 million in Q3 2012, and down 63.29% quarter-over-quarter from -$7.9 million in Q2 2013.
Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2012 - 2013) Analysis & Trends
Jazz Pharmaceuticals' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$12.9 million for Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -12.90 Mn |
| Sep 30, 2013 | -12.90 Mn |
| Jun 30, 2013 | -7.90 Mn |
| Jun 30, 2013 | -7.90 Mn |
| Sep 30, 2012 | -900,000.00 |
| Sep 30, 2012 | -900,000.00 |